U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07325240) titled '24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients' on Jan. 01.
Brief Summary: The purpose of this study is to evaluate the effect on 24-hour IOP reduction of netarsudil-latanoprost fixed combination in one eye compared to latanoprost alone in the contralateral eye, dosed daily, 1 drop at night (QD, PM) in adult subjects, at least 18 years of age, with open angle glaucoma (OAG) or ocular hypertension (OHT).
Study Start Date: Nov. 21, 2025
Study Type: INTERVENTIONAL
Condition:
Open Angle Glaucoma
Ocular Hypertension
Intervention:
DRUG: Netarsudil 0.01%/latanoprost 0.005%...